- Putin tells Trump he won’t back down from goals in Ukraine, Kremlin says Reuters
- Putin tells Trump he won’t back down from goals in Ukraine, Kremlin says Dawn
- Putin insisted Russia ‘will not step back from goals’ in Ukraine in hour-long call to Trump, Kremlin says – Europe live The Guardian
- Trump to speak with Putin today, possible Zelenskiy call Friday The Express Tribune
- ‘Trump Could Get Offended’: Putin Rushes Out Of Event To Attend Phone Call NDTV
Author: admin
-
Putin tells Trump he won't back down from goals in Ukraine, Kremlin says – Reuters
-
Progress MS-31 to launch as ISS hosts private crew, prepares for another handover
Progress MS-31 to launch as ISS hosts private crew, prepares for another handover – NASASpaceFlight.com
Continue Reading
-
Progress MS-31 scheduled to launch as ISS hosts private crew, prepares for another handover
Progress MS-31 scheduled to launch as ISS hosts private crew, prepares for another handover – NASASpaceFlight.com
Continue Reading
-
Kimi Antonelli adamant he’s ‘not really worried’ as Mercedes rookie is questioned on contract reports
Kimi Antonelli has no concerns over his Formula 1 future with Mercedes, despite the Italian rookie and experienced team mate George Russell not yet being confirmed at the Silver Arrows for the 2026 season.
Antonelli is almost halfway through his debut campaign after replacing seven-time World Champion Lewis Hamilton in Mercedes’ driver line-up – highlights so far including a Sprint pole in Miami and podium finish in Canada.
However, neither 18-year-old Antonelli nor 27-year-old Russell have been announced as Mercedes drivers beyond 2025, as media reports continue to link F1 title holder Max Verstappen with Toto Wolff’s squad.
With Russell recently speaking of “conversations” between Mercedes and Verstappen, and the Briton’s assertion that “I don’t think I’ll be going anywhere”, Antonelli was asked where he stands with the team and his future.
“I’m not really worried about myself, I’m just trying to focus as much as possible on what I have to do to deliver the best performance as possible,” explained Antonelli. “I think the team has given me a lot of trust and is still doing so, and they’re also giving me time to grow.
“On my side, I think last weekend was not the best, but at the same time I’m really trying to work on my weak points, to try and reduce the [number] of mistakes.
“Of course, there’s a lot going on and a lot of talks, but at the end of the day, I’m just trying to focus on myself and deliver the best job as possible.”
Antonelli was then quizzed on the amicable scenes between himself and Verstappen after the youngster ran into the back of the Dutchman’s car on the opening lap last time out in Austria – and the importance of keeping good relations should they become team mates going forward.
“To be honest, I wasn’t really thinking about that,” he said. “I think it was just a way to show respect and to also… I acknowledge straight away that I did a mistake and obviously it was on me.
“I was sorry towards my team as well, because finishing a race on Lap 1 is never good, but also I took out Max, which was obviously not the plan. It was not on purpose and I just felt sorry towards him as well.
“Definitely I went to apologise to show respect and that I was sorry about what happened, but he was very nice towards me as well – he was very open and he understood my message.”
As for the weekend ahead, Antonelli is excited to get back behind the wheel at a Silverstone Circuit that brought his maiden Formula 2 victory last season.
“I’m very excited ahead of this weekend,” he commented. “I think Silverstone is always a very special one because the atmosphere is just incredible.
“I think it’s a good weekend to bounce back, especially after the difficult race in Austria, so I’m very excited to hit the track tomorrow and see what we’re going to be able to do.”
Continue Reading
-
Shein hit with €40mn fine in France over misleading discounts – Financial Times
- Shein hit with €40mn fine in France over misleading discounts Financial Times
- France fines Shein $47 million for deceptive business practices Al Arabiya English
- France Just Fined Shein €40M, Saying “You Can’t Greenwash Your Way Out of This” TipRanks
- France fines one of Amazon’s biggest Chinese retail competitors for misleading customers about discounts Times of India
- France fines retailer Shein 40 million euros for misleading discounts Reuters
Continue Reading
-
Seattle Storm to honour five-time Olympic champion Sue Bird with a statue
The Seattle Storm will unveil a statue of Team USA’s five-time Olympic women’s basketball champion Sue Bird on Sunday (17 August), becoming the first team in WNBA history to honor a former player this way.
The 44-year-old Bird spent her entire 21-season career with the Storm, winning four WNBA titles, earning 13 All-Star selections, and becoming the league’s all-time leader in assists.
With Team USA, she won five consecutive Olympic basketball gold medals from Athens 2004 through to Tokyo 2020 (held in 2021). She also has four FIBA World Cup titles.
“Sue’s legacy goes beyond basketball; she redefined who gets to lead and be celebrated,” Storm President Alisha Valavanis said in a statement.
The statue, created by renowned sculptor Julie Rotblatt-Amrany, symbolizes Bird’s lasting impact on basketball and Seattle.
“It’s not just for me, it’s for anyone chasing their dreams,” said Bird.
Continue Reading
-
OMRON Healthcare Issues Urgent Health Message on AFib, Heart Failure Risks in Response to New Research
“Progress made in reducing heart attack deaths provides a roadmap to address rising mortality rates from arrythmias, heart failure and hypertensive heart disease”
HOFFMAN ESTATES, Ill., July 3, 2025 /PRNewswire/ — Heart health leader OMRON Healthcare today issued an urgent health message across the U.S. to raise public awareness of rapidly increasing risks and rising mortality rates associated with arrythmias such as atrial fibrillation (AFib), heart failure, and heart disease from long-term high blood pressure, as identified in new research.
Published in the Journal of the American Heart Association1, new research focused on age-adjusted mortality rates for a variety of heart disease subtypes among adults 25 years and older in an analysis of Centers of Disease Control and Prevention (CDC) data from 1970 to 2022.
The analysis found heart disease accounted for nearly one-third of all deaths over the 52-year period2. During that period, heart attack deaths decreased while deaths from arrhythmias, heart failure, and hypertensive heart disease increased significantly.
“In this study, researchers noted that public awareness, early diagnosis, and treatment interventions played key roles in reducing the heart attack death rate”, said OMRON Healthcare North America Managing Director Alice Koehler. “That affirms the body of research showing 90 percent of heart disease is preventable3. We must remain diligent in preventing heart attacks and commit to early detection and proper treatment of AFib and heart failure.”
OMRON is providing the following guidance to reduce rising heart disease risks:
- Monitor your blood pressure regularly at home. Blood pressure fluctuates over time. Regular blood pressure monitoring at home, daily or weekly, can help with early identification of high blood pressure.
- Utilize new medical technology for early AFib detection. Early detection of AFib is now widely available for the first time for use at home. OMRON recently introduced blood pressure monitors with AI-powered AFib detection, a medical device first.
- Tap into a virtual heart health coaching app. Mobile apps, such as OMRON connect, can sync to blood pressure monitors and help flag changes in data, provide reminders, support behavior change, and can be used to send readings to your physician.
- Talk to your doctor. Ask questions about arrythmias, heart failure, and hypertensive heart disease, especially if these conditions run in your family. Inquire about technology that can be used at home to provide a complete picture of your heart health.
According to senior author of the research paper Latha Palaniappan, M.D., M.S., FAHA, associate dean for research and a professor of medicine at Stanford University School of Medicine4: “While heart attack deaths are down by 90 percent since 1970, heart disease hasn’t gone away. Now that people are surviving heart attacks, we are seeing a rise in other forms of heart disease like heart failure. The focus now must be on helping people age with strong, healthy hearts by preventing events, and prevention can start as early as childhood.”
As presented in the research paper:
In 1970, more than half of all people who died from heart disease (54 percent) died because of a heart attack. The age-adjusted death rate decreased 89 percent by 2022, when less than one-third of all heart disease deaths were caused by a heart attack.
Conversely, during this time, the age-adjusted death rate from all other types of heart disease (including heart failure, hypertensive heart disease and arrhythmia) increased by 81 percent, accounting for 47 percent of all heart disease deaths in 2022.
“Over this same 52-year period, OMRON Healthcare began offering blood pressure monitors for home use, sold more than 350 million units, and became the number one doctor and pharmacist recommended blood pressure monitor,” said Koehler. “Regular blood pressure monitoring and acting on that data can make a world of difference.”
“Our mission is Going for Zero heart attacks and strokes, and our mission calls us to address the most urgent heart health risks,” added Koehler. “The measurable progress made in reducing heart attack deaths provides a roadmap to address rising mortality rates from arrythmias, heart failure and hypertensive heart disease.”
For more information on blood pressure monitoring and AFib detection, visit OmronHealthcare.com.
About OMRON Healthcare, Inc.
OMRON Healthcare, Inc., is the world’s leading manufacturer and distributor of personal heart health products and an innovator in technologies supporting respiratory and pain management care. With over 50 years of medical device category leadership, OMRON is passionate about empowering people to take charge of their health at home through precise technology. Its market-leading products include a full range of home blood pressure monitors, nebulizers and TENS devices. The company’s mission is Going for Zero, the elimination of heart attacks and strokes. With more than 350 million devices sold globally, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals. OMRON Healthcare strives to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions. The company provides products and services in over 130 countries. For more information, visit OmronHealthcare.com.SOURCE OMRON Healthcare
Continue Reading
-
Johnny’s Happy Place marks 10 years supporting mental health
A community cafe founded in memory of a man who took his own life is celebrating its tenth anniversary this weekend.
Johnny’s Happy Place in Kettering, Northamptonshire, was set up in 2014 by the family of Johnny Mackay, who died at the age of 29 after years of drug and alcohol addiction and undiagnosed mental health issues.
The cafe offers free mental health sessions with trained counsellors, and art therapy.
Johnny’s mother, Denise McKay, 76, said: “It’s been a remarkable journey. We get more and more people in every week, and what surprises me most is that [the local community] is embracing us, supporting us financially, and becoming involved.”
In the wake of Mr McKay’s death, his family and friends were determined to honour his memory, and two months later they were offered an unused cafe space that became the foundation for Johnny’s Happy Place.
Ms McKay, who previously worked in the hotel trade and now also volunteers with the British Heart Foundation, said the cafe has been her lifeline.
“When Johnny died, I sort of gave up my life. I didn’t do anything, I just focused on this,” she said.
“Starting a cafe sounded preposterous at the time. None of us had any experience, but I’m so glad it was suggested. Every time I open the door, I’m pleased to be here.”
Ten years on, Ms McKay said strangers still share stories about Johnny with her.
“They knew him and they have such wonderful anecdotes,” she added.
Johnny’s Happy Place will hold its anniversary event at the cafe on 6 July.
Continue Reading
-
Community vaccination program reduces pneumonia deaths among elderly in Japan
A research team has evaluated the real-world impact of a community-based pneumococcal vaccination support program for older adults conducted in Sera Town, Hiroshima Prefecture, Japan.
Their work is published in the Journal of Epidemiology on May 5, 2025.
Pneumonia is one of the leading causes of death in Japan. Each year about 74,000 people die from pneumonia with 98 percent of these deaths occurring in people aged 65 and older. The bacteria Streptococcus pneumoniae is the primary cause of pneumonia.
In October 2014, Japan began a nationwide routine vaccination program for the elderly under the National Immunization Program with the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
Sera Town, a mountainous municipality in eastern Hiroshima Prefecture, jointly planned and implemented a pneumococcal vaccination support program with a research team at Hiroshima University in October 2010-well before the nationwide rollout. The program, which ran until March 2015, aimed to promote community health and provided PPSV23 vaccination to all residents aged 65 and older. The vaccine used in the project was approved in Japan at the time for elderly individuals. As part of this collaborative initiative, a five-year follow-up survey was conducted to assess the vaccine’s preventive effect against pneumonia.
Specifically, we sought to understand the impact of the PPSV23 vaccine on pneumonia incidence and mortality among the elderly population in a rural setting with a high aging rate.”
Aya Sugiyama, lecturer in the Department of Epidemiology Disease Control and Prevention at the Graduate School of Biomedical and Health Sciences, Hiroshima University
The Sera Town residents who took part in the project ranged in age from 70 to 114 years old, with a median age of 84.
To assess changes in mortality following the introduction of the vaccination program, the researchers used aggregated demographic data from Japan’s vital statistics covering the years 2000 to 2016. They applied an interrupted time series analysis to quantify the level and trend changes in mortality rates over time, specifically looking at the mortality rates before and after the vaccination project was introduced in the town. The study aimed to generate real-world evidence on the effectiveness of vaccination support programs in super-aged societies.
Their analysis of the data showed them that the pneumococcal vaccination support program for older residents in Sera Town was associated with a 25 percent reduction in pneumonia-related mortality. “Notably, it reversed the previously increasing trend in pneumonia mortality in the community,” said Sugiyama.
The study also provided valuable data on the actual incidence of pneumonia among vaccinated older adults, with an incidence rate of 20.3 cases per 1,000 person-years. Scientists use the person-year method in studies where they follow individuals over a period of time. A person-year is one person being followed for one year.
“These findings underscore both the public health significance of local vaccination efforts and the burden of pneumonia in aging populations,” said Sugiyama.
The research team sees the findings as particularly relevant for Japan, which has the most aged population in the world. “With the completion of this evaluation, the next step is to share these findings to inform future discussions on community-based vaccination strategies. While further research is needed, we hope that our results will serve as a reference for regions exploring effective approaches to pneumonia prevention in older adults,” said Sugiyama.
The research team includes Aya Sugiyama, Kanon Abe, Hirohito Imada, Bunlorn Sun, Golda Ataa Akuffo, Tomoyuki Akita, Shingo Fukuma, Junko Tanaka, and Noboru Hattori from Hiroshima University; Masaaki Kataoka from Sera Central Public Hospital; and Kentaro Tokumo from Sera Central Public Hospital, Hiroshima University, and Hiroshima University Hospital.
The research is funded by the Sera Town municipality.
Source:
Journal reference:
Sugiyama, A., et al. (2024). Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-Based Study. Journal of Epidemiology. doi.org/10.2188/jea.je20240285.
Continue Reading
-
Largest piece of Mars on Earth could go for millions at auction | Features
Largest piece of Mars on Earth could go for millions at auction | Features | homenewshere.com
We recognize you are attempting to access this website from a country belonging to the European Economic Area (EEA) including the EU which
enforces the General Data Protection Regulation (GDPR) and therefore access cannot be granted at this time.Continue Reading